Brief: Astellas And Peptidream Enter Into Research And License Agreement

PeptiDream

25/07/2023 12:34

July 25 (Reuters) - PeptiDream Inc  4587.T :
    * ASTELLAS AND PEPTIDREAM ENTER INTO RESEARCH COLLABORATION
AND
LICENSE AGREEMENT TO DISCOVER NOVEL TARGETED PROTEIN DEGRADERS
    * ASTELLAS PHARMA INC- ASTELLAS WILL PROVIDE PEPTIDREAM WITH
AN
UPFRONT PAYMENT OF ¥3.0 BILLION
    * ASTELLAS PHARMA INC- PEPTIDREAM IS ELIGIBLE TO RECEIVE
DISCOVERY, DEVELOPMENT AND COMMERCIAL SALES MILESTONES OF UP TO
¥20.6 BILLION PER TARGET
    * ASTELLAS PHARMA INC- PEPTIDREAM ALSO ELIGIBLE TO RECEIVE
SINGLE-DIGIT PERCENT ROYALTY PAYMENTS ON NET SALES OF ANY
PRODUCTS ARISING FROM COLLABORATION

Source text for Eikon:  ID:nBw7rC9QBa 
Further company coverage:  4587.T 

 ((Reuters.Briefs@thomsonreuters.com;))